Cargando…

Protective Potential of Maresins in Cardiovascular Diseases

Cardiovascular diseases are the leading causes of global mortality. Growing evidence suggests that unresolved inflammation contributes to the chronicity, progression and morbidity of many cardiovascular diseases, thus emphasizing the urgent need to illuminate the mechanisms controlling inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Min, He, Huixiang, Chen, Lihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289265/ https://www.ncbi.nlm.nih.gov/pubmed/35859590 http://dx.doi.org/10.3389/fcvm.2022.923413

Ejemplares similares

Metformin Protects Cardiovascular Health in People With Diabetes
por: Chen, Chong, et al.
Publicado: (2022)

Iron in Cardiovascular Disease: Challenges and Potentials
por: Li, Shizhen, et al.
Publicado: (2021)

The therapeutic potential of sphingolipids for cardiovascular diseases
por: Ya'ar Bar, Sapir, et al.
Publicado: (2023)

Maresin-1 and Inflammatory Disease
por: Saito-Sasaki, Natsuko, et al.
Publicado: (2022)

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases
por: Zou, Yifei, et al.
Publicado: (2023)

Potential of ATP5MG to Treat Metabolic Syndrome-Associated Cardiovascular Diseases
por: Liu, Lianyong, et al.
Publicado: (2022)

Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
por: Buurma, Marleen, et al.
Publicado: (2019)

Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger
por: Jadli, Anshul S., et al.
Publicado: (2021)

Research trends in transient receptor potential vanilloid in cardiovascular disease: Bibliometric analysis and visualization
por: Zhang, Lingfeng, et al.
Publicado: (2023)

Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)

Decreased Serum Maresin 1 Concentration Is Associated With Postmenopausal Osteoporosis: A Cross-Sectional Study
por: Wu, Jing, et al.
Publicado: (2022)

The Protective Effects of Maresin 1 in the OVA-Induced Asthma Mouse Model
por: Ou, Guochun, et al.
Publicado: (2021)

Stem Cell-Derived Exosomes Potential Therapeutic Roles in Cardiovascular Diseases
por: Jayaraman, Selvaraj, et al.
Publicado: (2021)

Cardiovascular health and potential cardiovascular risk factors in young athletes
por: Grabitz, Carl, et al.
Publicado: (2023)

An Update on Cardiovascular Risk Factors After Kawasaki Disease
por: Zeng, Yuan-Yuan, et al.
Publicado: (2021)

Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases
por: Dagher, Olina, et al.
Publicado: (2021)

Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022)

Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
por: Chen, Yiru, et al.
Publicado: (2023)

Maresins: The Mainstay in Periodontal Resolution
por: Gireddy, Hima Bindu, et al.
Publicado: (2022)

Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy
por: Xi, Yangbo, et al.
Publicado: (2022)

Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
por: Liu, Yifei, et al.
Publicado: (2023)

Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges
por: Tintut, Yin, et al.
Publicado: (2018)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis
por: Ye, Zhen, et al.
Publicado: (2022)

Critical roles of m(6)A methylation in cardiovascular diseases
por: Zhang, Xinmin, et al.
Publicado: (2023)

Roles of Ferroptosis in Cardiovascular Diseases
por: Guo, Yuting, et al.
Publicado: (2022)

Associations Between Serum Soluble α-Klotho and the Prevalence of Specific Cardiovascular Disease
por: Xu, Jun-Peng, et al.
Publicado: (2022)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
por: He, Nana, et al.
Publicado: (2021)

The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
por: Chen, Zhenzhen, et al.
Publicado: (2021)

Pyroptosis: Role and Mechanisms in Cardiovascular Disease
por: Chen, Xinzhe, et al.
Publicado: (2022)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

Experimental Rodent Models of Cardiovascular Diseases
por: Jia, Tian, et al.
Publicado: (2020)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Ideal Cardiovascular Health in Young Adults With Established Cardiovascular Diseases
por: Leopold, Jane A., et al.
Publicado: (2022)

Maresin 1 Mitigates Inflammatory Response and Protects Mice from Sepsis
por: Li, Ruidong, et al.
Publicado: (2016)

The role of m5C methyltransferases in cardiovascular diseases
por: Wang, Yan-Yue, et al.
Publicado: (2023)

Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases
por: Tang, Shi, et al.
Publicado: (2018)

Circular RNAs as Competing Endogenous RNAs in Cardiovascular and Cerebrovascular Diseases: Molecular Mechanisms and Clinical Implications
por: Min, Xue, et al.
Publicado: (2021)

Editorial: Hypoxia in cardiovascular disease
por: Bilo, Grzegorz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1m46hg7d7b6hhr11rbagtluejm